Parameters | Changes done | Tenofovir | Darunavir | Emtricitabine | Cobicistat |
---|---|---|---|---|---|
Change in flow rate | Area* | Area* | Area* | Area* | |
0.9 mL | 59,662 | 345,373 | 428,300 | 36,922 | |
1 mL | 62,377 | 343,268 | 410,983 | 37,868 | |
1.1 mL | 61,702 | 330,567 | 403,890 | 36,036 | |
Organic composition in mobile phase | 10%less | 60,835 | 334,251 | 418,302 | 36,554 |
Actual | 62,377 | 343,268 | 410,983 | 37,868 | |
10% more | 61,473 | 319,463 | 420,831 | 37,831 | |
Detection wavelength | 252 nm | 59,870 | 325,549 | 408,822 | 37,402 |
254 nm | 62,377 | 343,268 | 410,983 | 37,868 | |
256 nm | 61,352 | 338,546 | 412,297 | 36,451 | |
% RSD | – | 1.64 | 1.85 | 1.89 | 1.32 |